Advanced Technology Solutions

Generic Wellbutrin Sr

Eon, a Laurelton-based generic drug company, said Wednesday that the 100mg version of the drug had generic wellbutrin sr been approved by the U. Additionally, where strategically appropriate, IMPAX has developed marketing partnerships to fully generic wellbutrin sr leverage its technology platform. For generic wellbutrin sr press releases and other company information, visit the Eon Labs, Inc. (Nasdaq: ELAB) generic wellbutrin sr announced today that it received final approval for Bupropion HCl, ER 150mg tablets, the generic equivalent of Wellbutrin SR(R)*150mg tablets. During generic wellbutrin sr the first quarter of 2004, we satisfied the remaining $2.
5 million refundable deposit obligation to Teva in full by issuing 160,751 shares of our common stock to Teva. Pursuant to Teva's existing strategic generic wellbutrin sr alliance agreement with IMPAX, Teva has U. The convertible debenture generic wellbutrin sr financing completed on April 5, 2004 provides us with additional financial resources going forward.

" Commenting generic wellbutrin sr on the Company's product pipeline, Larry Hsu, Ph. , IMPAX's President, said, "The launch of our generic Wellbutrin SR represents IMPAX's single largest product opportunity to date.
Website at www.

During the quarter, we received final approvals for generic versions of Declomycin and Claritin(R)-D 24-Hour. Food and Drug Administration (FDA) has granted final marketing approval to the Company's Abbreviated New generic wellbutrin sr drug Application (ANDA) for its generic version of Wellbutrin(R) SR (Bupropion Hydrochloride) 150 mg Controlled Release Tablets. (Nasdaq:IPXL) today announced that the U. The FDA had generic wellbutrin sr previously granted final approval for the Company's application for the 100 mg strength. Is one of the leading generic pharmaceutical companies in the U. IMPAX's ANDA filings with the Food and Drug Administration (FDA) contain Paragraph IV certifications under the Hatch-Waxman Amendments stating IMPAX's belief that its bupropion hydrochloride extended release tablets do not infringe the Glaxo Wellcome listed generic wellbutrin sr patents on Wellbutrin SR and Zyban. Is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. IMPAX markets its generic products through its Global Pharmaceuticals division and intends to market its branded products through the IMPAX Pharmaceuticals division. Eon Labs is a generic pharmaceutical company specializing in developing, licensing, manufacturing, selling and distributing a broad range of prescription pharmaceutical products. These factors and additional information are discussed in the Company's filings with the Securities and Exchange Commission and statements in this release should be evaluated in light of these Generic wellbutrin sr important factors. This temporary restraining order is separate from, and in addition to, the temporary restraining order reportedly entered by a court in New York, in connection with Eon's ongoing patent infringement litigation with GlaxoSmithKline.